
Pancham Bakshi
Examiner (ID: 9693, Phone: (571)270-3463 , Office: P/1671 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1671, 1621, 1673, 1623 |
| Total Applications | 1499 |
| Issued Applications | 1032 |
| Pending Applications | 147 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15160617
[patent_doc_number] => 10485781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Aminocarbonylcarbamate compounds
[patent_app_type] => utility
[patent_app_number] => 16/395422
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395422 | Aminocarbonylcarbamate compounds | Apr 25, 2019 | Issued |
Array
(
[id] => 19195282
[patent_doc_number] => 11992500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Use of methylation inhibitors for the treatment of autoimmune diseases
[patent_app_type] => utility
[patent_app_number] => 17/050526
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 52
[patent_no_of_words] => 19945
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050526 | Use of methylation inhibitors for the treatment of autoimmune diseases | Apr 25, 2019 | Issued |
Array
(
[id] => 15038455
[patent_doc_number] => 20190330232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => COMPOSITIONS AND METHODS OF REGULATING GLUCOSE HOMEOSTASIS AND INSULIN ACTION
[patent_app_type] => utility
[patent_app_number] => 16/387268
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16387268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/387268 | Compositions and methods of regulating glucose homeostasis and insulin action | Apr 16, 2019 | Issued |
Array
(
[id] => 18050655
[patent_doc_number] => 11524021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Use of ginsenoside M1 for manufacturing medicament for treating oral cancer
[patent_app_type] => utility
[patent_app_number] => 16/958902
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 5569
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958902
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958902 | Use of ginsenoside M1 for manufacturing medicament for treating oral cancer | Apr 16, 2019 | Issued |
Array
(
[id] => 14864583
[patent_doc_number] => 20190282533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Compositions and Methods for Lowering Triglycerides Without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
[patent_app_type] => utility
[patent_app_number] => 16/384230
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384230 | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy | Apr 14, 2019 | Issued |
Array
(
[id] => 15451043
[patent_doc_number] => 20200038345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/383480
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383480 | Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms | Apr 11, 2019 | Issued |
Array
(
[id] => 16663862
[patent_doc_number] => 10933084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Compositions and methods for treating elastic fiber breakdown
[patent_app_type] => utility
[patent_app_number] => 16/383033
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9789
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383033 | Compositions and methods for treating elastic fiber breakdown | Apr 11, 2019 | Issued |
Array
(
[id] => 16760971
[patent_doc_number] => 20210106552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING SALVIANOLIC ACID B
[patent_app_type] => utility
[patent_app_number] => 17/046577
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046577 | METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING SALVIANOLIC ACID B | Apr 10, 2019 | Pending |
Array
(
[id] => 14712689
[patent_doc_number] => 20190247408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => TREATMENT OF RETT SYNDROME
[patent_app_type] => utility
[patent_app_number] => 16/377875
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377875 | Treatment of Rett syndrome | Apr 7, 2019 | Issued |
Array
(
[id] => 15420617
[patent_doc_number] => 10543210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Inhibitors of multidrug resistance transporter P-glycoprotein
[patent_app_type] => utility
[patent_app_number] => 16/366674
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 13784
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366674 | Inhibitors of multidrug resistance transporter P-glycoprotein | Mar 26, 2019 | Issued |
Array
(
[id] => 16596576
[patent_doc_number] => 20210023107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/982979
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982979 | USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS | Mar 21, 2019 | Abandoned |
Array
(
[id] => 19922953
[patent_doc_number] => 12297224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Crystal form, preparation method, and application of 4'-substituted nucleoside
[patent_app_type] => utility
[patent_app_number] => 17/604451
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 957
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604451 | Crystal form, preparation method, and application of 4'-substituted nucleoside | Mar 20, 2019 | Issued |
Array
(
[id] => 14893807
[patent_doc_number] => 20190290669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM
[patent_app_type] => utility
[patent_app_number] => 16/359943
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359943 | N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM | Mar 19, 2019 | Abandoned |
Array
(
[id] => 14774807
[patent_doc_number] => 20190262301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNITY
[patent_app_type] => utility
[patent_app_number] => 16/357397
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357397 | Compounds and methods for treating autoimmunity | Mar 18, 2019 | Issued |
Array
(
[id] => 14624019
[patent_doc_number] => 20190225377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Alkoxysilylamine Compounds and Applications Thereof
[patent_app_type] => utility
[patent_app_number] => 16/355177
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16355177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/355177 | Alkoxysilylamine compounds and applications thereof | Mar 14, 2019 | Issued |
Array
(
[id] => 18643275
[patent_doc_number] => 11767335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Method for preparing organochlorosilanes
[patent_app_type] => utility
[patent_app_number] => 17/438004
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5143
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 348
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438004 | Method for preparing organochlorosilanes | Mar 11, 2019 | Issued |
Array
(
[id] => 14833351
[patent_doc_number] => 20190275076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => DIETARY FIBER COMPOSITIONS FOR CURATIVE OR PROPHYLACTIC TREATMENT OF OBESITY AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/296278
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/296278 | DIETARY FIBER COMPOSITIONS FOR CURATIVE OR PROPHYLACTIC TREATMENT OF OBESITY AND OTHER CONDITIONS | Mar 7, 2019 | Abandoned |
Array
(
[id] => 16518677
[patent_doc_number] => 10869879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Combinations to treat cancer
[patent_app_type] => utility
[patent_app_number] => 16/295092
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 89
[patent_no_of_words] => 27652
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295092 | Combinations to treat cancer | Mar 6, 2019 | Issued |
Array
(
[id] => 16518677
[patent_doc_number] => 10869879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Combinations to treat cancer
[patent_app_type] => utility
[patent_app_number] => 16/295092
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 89
[patent_no_of_words] => 27652
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295092 | Combinations to treat cancer | Mar 6, 2019 | Issued |
Array
(
[id] => 16169472
[patent_doc_number] => 10711020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Tricyclic sulfones as RORg modulators
[patent_app_type] => utility
[patent_app_number] => 16/295378
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59600
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295378 | Tricyclic sulfones as RORg modulators | Mar 6, 2019 | Issued |